Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SBC Medical Group HoldingsSBC -0.32%21 ROE % is 17.96% as of Mar. 2026, which is 29% below its 10-year median of 25.32. GuruFocus rates SBC with a GF Score™ of 21/100. The stock has 3 warning signs investors should review. Among 1,059 Business Services companies, SBC Medical Group Holdings ranks better than 75.54% on this metric.
The historical rank and industry rank for SBC Medical Group Holdings's ROE % or its related term are showing as below:
SBC'
s ROE % Range Over the Past 10 Years
Min: 6 Med: 25.32 Max: 31.83
Current: 16.68
During the past 4 years, SBC Medical Group Holdings's highest ROE % was 31.83%. The lowest was 6.00%. And the median was 25.32%.
SBC's ROE % is ranked better than 75.54% of 1059
companies
in the Business Services industry
Industry Median: 8.1
vs SBC: 16.68
SBC Medical Group Holdings (NAS:SBC) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Consulting Services subindustry, SBC Medical Group Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SBC Medical Group Holdings ROE % vs Business Services Industry
For the Business Services industry and Industrials sector, SBC Medical Group Holdings's ROE % distribution charts can be found below:
* The bar in red indicates where SBC Medical Group Holdings's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
SBC Medical Group Holdings (SBC) has a ROE % of 17.96% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on SBC Medical Group Holdings and its competitors. This is 29% below median its historical median of 25.32. Over the past decade, SBC Medical Group Holdings' ROE % has ranged from 6.00 to 31.83. According to the industry distribution chart, SBC Medical Group Holdings ranks #259 out of 1059 companies in the Business Services industry, placing it in the top 24.5%.
Is SBC Medical Group Holdings' ROE % too high?
SBC Medical Group Holdings' current ROE % of 17.96% is 29% below median its 10-year median of 25.32. Over the past 10 years, this metric has ranged from a low of 6.00 to a high of 31.83. The Business Services industry median ROE % is 8.10. SBC Medical Group Holdings' value of 17.96% is 121.7% above this industry median. Based on the distribution chart, SBC Medical Group Holdings ranks #259 out of 1059 companies in the Business Services industry, which is in the top quartile — a strong position relative to peers. Overall, SBC Medical Group Holdings has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does SBC Medical Group Holdings' ROE % compare to ROMA and EGG?
According to the Business Services industry distribution chart, SBC Medical Group Holdings ranks #259 out of 1059 companies for ROE %. This places SBC Medical Group Holdings in the top 25% of its industry — outperforming the majority of peers. The industry median ROE % is 8.10. SBC Medical Group Holdings' value of 17.96% is 121.7% above this benchmark. Historically, SBC Medical Group Holdings' own ROE % has ranged from 6.00 to 31.83 over the past decade. While the company's 10-year median is 25.32 vs. the industry median of 8.10, SBC Medical Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Business Services company?
The median ROE % among Business Services companies is 8.10, based on 1,059 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SBC Medical Group Holdings's current ROE % of 17.96% is 121.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on SBC Medical Group Holdings and its competitors. For the Business Services industry, the median ROE % is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SBC Medical Group Holdings's current ROE % is 17.96%, which is 29% below median its own 10-year median of 25.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SBC Medical Group Holdings stock overvalued right now?
SBC Medical Group Holdings (SBC) has a current ROE % of 17.96%. The current ROE % is 17.96%, which is 29% below median its 10-year median of 25.32 and 121.7% above the Business Services industry median of 8.10. SBC Medical Group Holdings' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For SBC Medical Group Holdings (SBC), the current ROE % is 17.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). The firm generates revenue mostly from these management services.
21GF Score
Get the complete analysis for SBC
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SBC has been successfully added to your 
